跳转至内容
Merck
CN
  • Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma.

Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma.

Anti-cancer agents in medicinal chemistry (2020-08-05)
Xiao-Jing Ye, Jian-Guang Yang, Ya-Qin Tan, Xiao-Jie Chen, Gang Zhou
摘要

Our previous work demonstrated upregulated CD47 in Oral Squamous Cell Carcinoma (OSCC). In the present study, we aimed to investigate the effects of CD47 on tumor cell development and phagocytosis in OSCC and elucidate the underlying mechanisms. The proliferation, apoptosis, migration, and invasion of oral cancer cells were analyzed after knocking down the expression of CD47. The effects of CD47 on tumor development were also evaluated using a murine model of OSCC. The involvement of CD47 in the phagocytosis of oral cancer cells was identified. Cell proliferation was suppressed by knocking down the expression of CD47 in human OSCC cell line Cal-27 cells but there was no change in the apoptosis rate. Moreover, impaired expression of CD47 inhibited the migration and invasion of Cal-27 cells. Furthermore, we found that nude mice injected with CD47 knockeddown Cal-27 cells displayed decreased tumor volumes at week 9 compared to xenograft transplantations of blank Cal-27 cells. In addition, in vitro phagocytosis of Cal-27 cells by macrophages was significantly enhanced after the knockdown of CD47, which positively correlated with compromised STAT3/JAK2 signaling. In summary, the knockdown of CD47 downregulated the development of OSCC and increased the phagocytosis of Cal-27 cells, indicating that CD47 might be a promising therapeutic target.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
庆大霉素 硫酸盐, potency: ≥590 I.U. Gentamicin base per mg
Sigma-Aldrich
PKH67 Green Fluorescent Cell Linker Kit,用于常规细胞膜标记, Distributed for Phanos Technologies